Chiara Intrivici

Chemo-Immunotherapy of Metastatic Colorectal Carcinoma With Gemcitabine Plus FOLFOX 4 Followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Induces Strong Immunologic and Antitumor Activity in Metastatic Colon Cancer Patients

Pierpaolo Correale, Maria Grazia Cusi, Kwong Y. Tsang et al. · Journal of Clinical Oncology · 2005 · 169 citations · Full text

Medicine, Immunology, Oncology +17

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

Paola Sperone, Annamaria Ferrero, Fulvia Daffara et al. · Endocrine Related Cancer · 2010 · 162 citations · Full text

Medicine, Oncology, Pharmacology +15

Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study

Viviana Bazan, L Bruno, Claudia Augello et al. · Annals of Oncology · 2006 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17

Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer

R. Charles Coombes, Holly Tovey, Lucy Kilburn et al. · JAMA Oncology · 2021 · 47 citations · Full text

Medicine, Oncology, Pharmacology +15

Up‐regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration‐resistant prostate cancer

Ngar‐Yee Huen, Alan Lap‐Yin Pang, Jo A. Tucker et al. · International Journal of Cancer · 2013 · 40 citations · Full text

Life Sciences, Immunology, Oncology +14